Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein
暂无分享,去创建一个
E. Yow | H. Barnhart | C. Sandborg | G. Evans | D. McCurdy | E. Silverman | L. Wagner-Weiner | R. Silver | J. Soep | L. Schanberg | S. Bowyer | H. Brunner | S. Thompson | D. Sherry | D. Levy | L. Jung | C. Wallace | E. von Scheven | N. Ilowite | G. Higgins | S. Ardoin | L. Imundo | N. Singer | Y. Kimura | A. Eberhard | A. Reed | E. Scheven | K. Mieszkalski | L. Punaro | M. Klein-Gitelman | Lynn Punaro
[1] E. Yow,et al. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. , 2012, Arthritis and rheumatism.
[2] J. Musial,et al. Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study , 2011, Arthritis research & therapy.
[3] A. Beyerlein,et al. The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus , 2011, Cardiovascular diabetology.
[4] R. Collins,et al. C-reactive protein in the Heart Protection Study – Authors' reply , 2011, The Lancet.
[5] Heart Protection Study Collaborative Group. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study , 2011, The Lancet.
[6] L. Magder,et al. Lupus Atherosclerosis Prevention Study (LAPS) , 2010, Annals of the rheumatic diseases.
[7] S. Srinivasan,et al. Progression of segment-specific carotid artery intima-media thickness in young adults (from the Bogalusa Heart Study). , 2011, The American journal of cardiology.
[8] E. Yow,et al. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort , 2010, Lupus.
[9] D. Gladman,et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus , 2010, Arthritis care & research.
[10] R. Oberhoffer,et al. Sex differences of carotid intima-media thickness in healthy children and adolescents. , 2009, Atherosclerosis.
[11] J Shepherd,et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.
[12] E. Yow,et al. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. , 2009, Arthritis and rheumatism.
[13] R. Shamburek,et al. The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. , 2009, Atherosclerosis.
[14] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[15] M. Petri. Sex hormones and systemic lupus erythematosus , 2008, Lupus.
[16] R. Devereux,et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. , 2007, Arthritis and rheumatism.
[17] Diederick E Grobbee,et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. , 2007, JAMA.
[18] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[19] Mimi Y. Kim,et al. Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.
[20] H. Büller,et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.
[21] E. Sijbrands,et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia , 2004, The Lancet.
[22] J. Schwartz,et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. , 2003, The New England journal of medicine.
[23] Diederick E Grobbee,et al. Carotid Intima-Media Thickness Measurements in Intervention Studies: Design Options, Progression Rates, and Sample Size Considerations: A Point of View , 2003, Stroke.
[24] D. Mannino,et al. C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. , 2003, Clinical chemistry.
[25] P. Ridker. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.
[26] J. Varni,et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. , 2002, Arthritis and rheumatism.
[27] Eary,et al. CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .
[28] J. Varni,et al. The PedsQL: measurement model for the pediatric quality of life inventory. , 1999, Medical care.
[29] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[30] L. Kuller,et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.
[31] Gérard Siest,et al. Intima–media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure , 1998, Journal of hypertension.
[32] A. Folsom,et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.
[33] Arno W. Hoes,et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.
[34] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[35] R. D'Agostino,et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.
[36] D. Symmons,et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.
[37] B. Sonesson,et al. Diameter and compliance in the human common carotid artery--variations with age and sex. , 1995, Ultrasound in medicine & biology.
[38] Ncep Expert Panel on Blood Cholesterol Levels in Childr Adolescents. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. , 1992, Pediatrics.
[39] C. Irwin,et al. Validity of self-report of pubertal maturation in early adolescents. , 1990, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[40] H. C. Stary. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. , 1989, Arteriosclerosis.
[41] H. C. Stary,et al. Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children. , 1987, Atherosclerosis.